financetom
Business
financetom
/
Business
/
Quantum-Si Appoints Todd Bennett as Chief Commercial Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Quantum-Si Appoints Todd Bennett as Chief Commercial Officer
Aug 29, 2024 9:05 AM

05:36 PM EDT, 08/27/2024 (MT Newswires) -- Quantum-Si (QSI) said Tuesday it appointed Todd Bennett as chief commercial officer, starting Sept. 16.

Grace Johnston, the current commercial chief, has resigned and will provide transitional support through Sept. 6.

Bennett has previously worked at Luminex, Abbott, Roche and Immucor.

John Vieceli and Lindsay Thompson were named as chief product officer and chief human resources officer, respectively, according to the company.

Quantum-Si stock was up more than 1% in recent after-hours activity.

Price: 0.9900, Change: +0.01, Percent Change: +1.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Campbell's Names Kelly Palumbo as Chief Accounting Officer
Campbell's Names Kelly Palumbo as Chief Accounting Officer
Sep 4, 2025
05:41 PM EDT, 09/04/2025 (MT Newswires) -- Campbell's (CPB) said late Thursday it has appointed Kelly Palumbo as chief accounting officer, starting Sep. 22. Palumbo succeeds Stan Polomski, who has been named senior vice president of Business Process Optimization within the Enterprise Transformation Office, the company said. ...
Belden Insider Sold Shares Worth $521,119, According to a Recent SEC Filing
Belden Insider Sold Shares Worth $521,119, According to a Recent SEC Filing
Sep 4, 2025
05:42 PM EDT, 09/04/2025 (MT Newswires) -- Brian Lieser, Executive Vice President, Solutions, on September 02, 2025, sold 4,097 shares in Belden (BDC) for $521,119. Following the Form 4 filing with the SEC, Lieser has control over a total of 31,292 common shares of the company, with 30,787 shares held directly and 505 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/913142/000095017025113086/xslF345X05/ownership.xml ...
Zumiez Fiscal Q2 Loss Widens, Net Sales Rise; Shares Advance After Hours
Zumiez Fiscal Q2 Loss Widens, Net Sales Rise; Shares Advance After Hours
Sep 4, 2025
05:41 PM EDT, 09/04/2025 (MT Newswires) -- Zumiez ( ZUMZ ) reported a fiscal Q2 loss late Thursday of $0.06 per diluted share, widening from the $0.04 loss a year earlier. Three analysts polled by FactSet expected a loss of $0.11. Net sales in the three months ended Aug. 2 rose to $214.3 million from $210.2 million a year earlier....
Arrowhead Pharmaceuticals Insider Sold Shares Worth $375,000, According to a Recent SEC Filing
Arrowhead Pharmaceuticals Insider Sold Shares Worth $375,000, According to a Recent SEC Filing
Sep 4, 2025
05:41 PM EDT, 09/04/2025 (MT Newswires) -- James C Hamilton, Chief Medical Officer, on September 02, 2025, sold 15,000 shares in Arrowhead Pharmaceuticals ( ARWR ) for $375,000. Following the Form 4 filing with the SEC, Hamilton has control over a total of 247,122 common shares of the company, with 247,122 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/879407/000183075525000007/xslF345X05/wk-form4_1757021819.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved